{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T13:04:29Z","timestamp":1791551069530,"version":"4.3.4"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,3,16]],"date-time":"2013-03-16T00:00:00Z","timestamp":1363392000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s12026-013-8389-8","type":"journal-article","created":{"date-parts":[[2013,3,15]],"date-time":"2013-03-15T22:21:02Z","timestamp":1363386062000},"page":"163-171","source":"Crossref","is-referenced-by-count":75,"title":["The immunology of Leishmania\/HIV co-infection"],"prefix":"10.1007","volume":"56","author":[{"given":"Ifeoma","family":"Okwor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jude Eze","family":"Uzonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,16]]},"reference":[{"issue":"5","key":"8389_CR1","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","volume":"7","author":"J Alvar","year":"2012","unstructured":"Alvar J, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE. 2012;7(5):e35671.","journal-title":"PLoS ONE"},{"issue":"14","key":"8389_CR2","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S1286-4579(00)01331-9","volume":"2","author":"S Kamhawi","year":"2000","unstructured":"Kamhawi S. The biological and immunomodulatory properties of sand fly saliva and its role in the establishment of Leishmania infections. Microbes Infect. 2000;2(14):1765\u201373.","journal-title":"Microbes Infect"},{"issue":"Suppl 1","key":"8389_CR3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1179\/000349803225002516","volume":"97","author":"R Molina","year":"2003","unstructured":"Molina R, Gradoni L, Alvar J. HIV and the transmission of Leishmania. Ann Trop Med Parasitol. 2003;97(Suppl 1):29\u201345.","journal-title":"Ann Trop Med Parasitol"},{"issue":"1","key":"8389_CR4","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1600-065X.2010.00983.x","volume":"240","author":"E Mougneau","year":"2011","unstructured":"Mougneau E, Bihl F, Glaichenhaus N. Cell biology and immunology of Leishmania. Immunol Rev. 2011;240(1):286\u201396.","journal-title":"Immunol Rev"},{"issue":"8","key":"8389_CR5","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2165\/00128071-200203080-00006","volume":"3","author":"PC Melby","year":"2002","unstructured":"Melby PC. Vaccination against cutaneous leishmaniasis: current status. Am J Clin Dermatol. 2002;3(8):557\u201370.","journal-title":"Am J Clin Dermatol"},{"key":"8389_CR6","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.0105-2896.2004.00198.x","volume":"201","author":"P Scott","year":"2004","unstructured":"Scott P, et al. The development of effector and memory T cells in cutaneous leishmaniasis: the implications for vaccine development. Immunol Rev. 2004;201:318\u201338.","journal-title":"Immunol Rev"},{"issue":"2","key":"8389_CR7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.clindermatol.2006.05.008","volume":"25","author":"MS Bailey","year":"2007","unstructured":"Bailey MS, Lockwood DN. Cutaneous leishmaniasis. Clin Dermatol. 2007;25(2):203\u201311.","journal-title":"Clin Dermatol"},{"key":"8389_CR8","unstructured":"WHO. HIV\/AIDS Fact Sheet. 2012 cited 2012; Available from: http:\/\/www.who.int\/mediacentre\/factsheets\/fs360\/en\/index.html ."},{"issue":"2","key":"8389_CR9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1017\/S0950268807009120","volume":"136","author":"S Dougan","year":"2008","unstructured":"Dougan S, et al. HIV in gay and bisexual men in the United Kingdom: 25\u00a0years of public health surveillance. Epidemiol Infect. 2008;136(2):145\u201356.","journal-title":"Epidemiol Infect"},{"key":"8389_CR10","unstructured":"Centre for Disease Control. Kaposi\u2019s sarcoma and pneumocystis pneumonia among homosexual men- New York City and California. Morb Mortal Wkly Rep. 1981;3."},{"issue":"8247","key":"8389_CR11","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0140-6736(81)92740-9","volume":"2","author":"KB Hymes","year":"1981","unstructured":"Hymes KB, et al. Kaposi\u2019s sarcoma in homosexual men-a report of eight cases. Lancet. 1981;2(8247):598\u2013600.","journal-title":"Lancet"},{"issue":"Suppl 1","key":"8389_CR12","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1002\/eji.200737441","volume":"37","author":"WC Greene","year":"2007","unstructured":"Greene WC. A history of AIDS: looking back to see ahead. Eur J Immunol. 2007;37(Suppl 1):S94\u2013102.","journal-title":"Eur J Immunol"},{"key":"8389_CR13","unstructured":"UNAIDS. Global report: UNAIDS Report on Global AIDS Epidemic. 2012."},{"key":"8389_CR14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-3-540-33397-5_5","volume":"303","author":"N Ray","year":"2006","unstructured":"Ray N, Doms RW. HIV-1 coreceptors and their inhibitors. Curr Top Microbiol Immunol. 2006;303:97\u2013120.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"7","key":"8389_CR15","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nm0702-673","volume":"8","author":"WC Greene","year":"2002","unstructured":"Greene WC, Peterlin BM. Charting HIV\u2019s remarkable voyage through the cell: basic science as a passport to future therapy. Nat Med. 2002;8(7):673\u201380.","journal-title":"Nat Med"},{"issue":"4","key":"8389_CR16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0092-8674(02)00864-4","volume":"110","author":"AR Schroder","year":"2002","unstructured":"Schroder AR, et al. HIV-1 integration in the human genome favors active genes and local hotspots. Cell. 2002;110(4):521\u20139.","journal-title":"Cell"},{"issue":"1","key":"8389_CR17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(01)00506-2","volume":"107","author":"JE Garrus","year":"2001","unstructured":"Garrus JE, et al. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell. 2001;107(1):55\u201365.","journal-title":"Cell"},{"issue":"3","key":"8389_CR18","first-page":"357","volume":"123","author":"I Cruz","year":"2006","unstructured":"Cruz I, et al. Leishmania\/HIV co-infections in the second decade. Indian J Med Res. 2006;123(3):357\u201388.","journal-title":"Indian J Med Res"},{"issue":"Suppl 1","key":"8389_CR19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1179\/000349803225002499","volume":"97","author":"P Desjeux","year":"2003","unstructured":"Desjeux P, Alvar J. Leishmania\/HIV co-infections: epidemiology in Europe. Ann Trop Med Parasitol. 2003;97(Suppl 1):3\u201315.","journal-title":"Ann Trop Med Parasitol"},{"issue":"7","key":"8389_CR20","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1093\/cid\/cir521","volume":"53","author":"PK Sinha","year":"2011","unstructured":"Sinha PK, et al. Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India. Clin Infect Dis. 2011;53(7):e91\u20138.","journal-title":"Clin Infect Dis"},{"key":"8389_CR21","unstructured":"Diro A, Hailu A, Lynen L. VL-HIV co-infection in East-Africa: current challenges and perspectives. In: 7th European congress on tropical medicine and international health. Barcelona, Spain; 2011."},{"issue":"Suppl 1","key":"8389_CR22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1179\/000349803225002552","volume":"97","author":"C Chicharro","year":"2003","unstructured":"Chicharro C, Alvar J. Lower trypanosomatids in HIV\/AIDS patients. Ann Trop Med Parasitol. 2003;97(Suppl 1):75\u20138.","journal-title":"Ann Trop Med Parasitol"},{"key":"8389_CR23","first-page":"14","volume-title":"Leishmania\/HIV co-infection in south-western Europe 1990\u20131998: a retrospective analysis f 965 cases","author":"WHO","year":"2000","unstructured":"WHO. Leishmania\/HIV co-infection in south-western Europe 1990\u20131998: a retrospective analysis f 965 cases. Geneva: World Health Orginization; 2000. p. 14."},{"issue":"2","key":"8389_CR24","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/CMR.10.2.298","volume":"10","author":"J Alvar","year":"1997","unstructured":"Alvar J, et al. Leishmania and human immunodeficiency virus coinfection: the first 10\u00a0years. Clin Microbiol Rev. 1997;10(2):298\u2013319.","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"8389_CR25","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/CMR.00061-07","volume":"21","author":"J Alvar","year":"2008","unstructured":"Alvar J, et al. The relationship between leishmaniasis and AIDS: the second 10\u00a0years. Clin Microbiol Rev. 2008;21(2):334\u201359. table of contents.","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"8389_CR26","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0738-081X(96)00046-6","volume":"14","author":"J Alvar","year":"1996","unstructured":"Alvar J, et al. AIDS and Leishmania infantum. New approaches for a new epidemiological problem. Clin Dermatol. 1996;14(5):541\u20136.","journal-title":"Clin Dermatol"},{"issue":"6","key":"8389_CR27","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1086\/382077","volume":"38","author":"PJ Hotez","year":"2004","unstructured":"Hotez PJ, et al. Combating tropical infectious diseases: report of the Disease Control Priorities in Developing Countries Project. Clin Infect Dis. 2004;38(6):871\u20138.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"8389_CR28","first-page":"275","volume":"123","author":"C Bern","year":"2006","unstructured":"Bern C, Chowdhury R. The epidemiology of visceral leishmaniasis in Bangladesh: prospects for improved control. Indian J Med Res. 2006;123(3):275\u201388.","journal-title":"Indian J Med Res"},{"issue":"2","key":"8389_CR29","first-page":"139","volume":"38","author":"DD Joshi","year":"2006","unstructured":"Joshi DD, Sharma M, Bhandari S. Visceral leishmaniasis in Nepal during 1980\u20132006. J Commun Dis. 2006;38(2):139\u201348.","journal-title":"J Commun Dis"},{"issue":"12","key":"8389_CR30","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1111\/j.1365-3156.2006.01735.x","volume":"11","author":"K Schenkel","year":"2006","unstructured":"Schenkel K, et al. Visceral leishmaniasis in southeastern Nepal: a cross-sectional survey on Leishmania donovani infection and its risk factors. Trop Med Int Health. 2006;11(12):1792\u20139.","journal-title":"Trop Med Int Health"},{"issue":"6","key":"8389_CR31","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1365-3156.2006.01647.x","volume":"11","author":"SP Singh","year":"2006","unstructured":"Singh SP, et al. Serious underreporting of visceral leishmaniasis through passive case reporting in Bihar, India. Trop Med Int Health. 2006;11(6):899\u2013905.","journal-title":"Trop Med Int Health"},{"key":"8389_CR32","unstructured":"UNAIDS. Global Report: UNAIDS Report on Global AIDS Epidemic. 2010."},{"key":"8389_CR33","unstructured":"UNAIDS. Global Report: UNIADS Report on Global AIDS Epidemic. 2009."},{"issue":"2","key":"8389_CR34","first-page":"73","volume":"31","author":"S Singh","year":"1999","unstructured":"Singh S, et al. A new focus of visceral leishmaniasis in sub-Himalayan (Kumaon) region of northern India. J Commun Dis. 1999;31(2):73\u20137.","journal-title":"J Commun Dis"},{"issue":"3","key":"8389_CR35","first-page":"473","volume":"123","author":"RL Gurubacharya","year":"2006","unstructured":"Gurubacharya RL, et al. Prevalence of visceral leishmania and HIV co-infection in Nepal. Indian J Med Res. 2006;123(3):473\u20135.","journal-title":"Indian J Med Res"},{"issue":"2","key":"8389_CR36","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0035-9203(03)90109-X","volume":"97","author":"RT Guiguemde","year":"2003","unstructured":"Guiguemde RT, et al. Leishmania major and HIV co-infection in Burkina Faso. Trans R Soc Trop Med Hyg. 2003;97(2):168\u20139.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6","key":"8389_CR37","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1365-2133.2004.06226.x","volume":"151","author":"P Couppie","year":"2004","unstructured":"Couppie P, et al. Comparative study of cutaneous leishmaniasis in human immunodeficiency virus (HIV)-infected patients and non-HIV-infected patients in French Guiana. Br J Dermatol. 2004;151(6):1165\u201371.","journal-title":"Br J Dermatol"},{"issue":"8","key":"8389_CR38","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1046\/j.1365-3156.2003.01088.x","volume":"8","author":"S Lyons","year":"2003","unstructured":"Lyons S, Veeken H, Long J. Visceral leishmaniasis and HIV in Tigray, Ethiopia. Trop Med Int Health. 2003;8(8):733\u20139.","journal-title":"Trop Med Int Health"},{"key":"8389_CR39","unstructured":"UNAIDS\/WHO. UNAIDS\/WHO AIDS Epidemic Updates. 2005."},{"issue":"3","key":"8389_CR40","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.trstmh.2011.10.012","volume":"106","author":"OB Ngouateu","year":"2012","unstructured":"Ngouateu OB, et al. Clinical features and epidemiology of cutaneous leishmaniasis and Leishmania major\/HIV co-infection in Cameroon: results of a large cross-sectional study. Trans R Soc Trop Med Hyg. 2012;106(3):137\u201342.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"8389_CR41","unstructured":"WHO. Report of the fifth consultative meeting on Leishmania\/HIV coinfection, 2007: Addis Ababa, Ethiopia."},{"issue":"3","key":"8389_CR42","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1645\/GE-1678.1","volume":"95","author":"EF Daher","year":"2009","unstructured":"Daher EF, et al. Clinical and epidemiological features of visceral leishmaniasis and HIV co-infection in fifteen patients from Brazil. J Parasitol. 2009;95(3):652\u20135.","journal-title":"J Parasitol"},{"issue":"5","key":"8389_CR43","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.trstmh.2011.01.006","volume":"105","author":"ET Nascimento","year":"2011","unstructured":"Nascimento ET, et al. The emergence of concurrent HIV-1\/AIDS and visceral leishmaniasis in Northeast Brazil. Trans R Soc Trop Med Hyg. 2011;105(5):298\u2013300.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"5","key":"8389_CR44","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.trstmh.2012.01.008","volume":"106","author":"M Orsini","year":"2012","unstructured":"Orsini M, et al. High frequency of asymptomatic Leishmania spp. infection among HIV-infected patients living in endemic areas for visceral leishmaniasis in Brazil. Trans R Soc Trop Med Hyg. 2012;106(5):283\u20138.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"8389_CR45","unstructured":"Lindoso JAL. Visceral Leishmaniasis\u2014HIV co-infection: emerging in South America. In: 7th European congress on tropical medicine and international health. Barcelona, Spain: Wiley Blackwell; 2011."},{"issue":"11","key":"8389_CR46","doi-asserted-by":"crossref","first-page":"7282","DOI":"10.1128\/JVI.69.11.7282-7285.1995","volume":"69","author":"R Bernier","year":"1995","unstructured":"Bernier R, et al. Activation of human immunodeficiency virus type 1 in monocytoid cells by the protozoan parasite Leishmania donovani. J Virol. 1995;69(11):7282\u20135.","journal-title":"J Virol"},{"issue":"3","key":"8389_CR47","first-page":"72","volume":"8","author":"Z Bentwich","year":"2003","unstructured":"Bentwich Z. Concurrent infections that rise the HIV viral load. J HIV Ther. 2003;8(3):72\u20135.","journal-title":"J HIV Ther"},{"key":"8389_CR48","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1186\/1471-2334-10-358","volume":"10","author":"JR Santos-Oliveira","year":"2010","unstructured":"Santos-Oliveira JR, et al. High levels of T lymphocyte activation in Leishmania-HIV-1 co-infected individuals despite low HIV viral load. BMC Infect Dis. 2010;10:358.","journal-title":"BMC Infect Dis"},{"issue":"18","key":"8389_CR49","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1056\/NEJMra032395","volume":"350","author":"J Stebbing","year":"2004","unstructured":"Stebbing J, Gazzard B, Douek DC. Where does HIV live? N Engl J Med. 2004;350(18):1872\u201380.","journal-title":"N Engl J Med"},{"issue":"9496","key":"8389_CR50","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","volume":"366","author":"HW Murray","year":"2005","unstructured":"Murray HW, et al. Advances in leishmaniasis. Lancet. 2005;366(9496):1561\u201377.","journal-title":"Lancet"},{"issue":"7","key":"8389_CR51","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.pt.2007.05.006","volume":"23","author":"R Garg","year":"2007","unstructured":"Garg R, Trudel N, Tremblay MJ. Consequences of the natural propensity of Leishmania and HIV-1 to target dendritic cells. Trends Parasitol. 2007;23(7):317\u201324.","journal-title":"Trends Parasitol"},{"issue":"21","key":"8389_CR52","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.2174\/0929867023368935","volume":"9","author":"K Kedzierska","year":"2002","unstructured":"Kedzierska K, Crowe SM. The role of monocytes and macrophages in the pathogenesis of HIV-1 infection. Curr Med Chem. 2002;9(21):1893\u2013903.","journal-title":"Curr Med Chem"},{"issue":"7","key":"8389_CR53","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1089\/aid.2006.22.619","volume":"22","author":"R Azzam","year":"2006","unstructured":"Azzam R, et al. Impaired complement-mediated phagocytosis by HIV type-1-infected human monocyte-derived macrophages involves a cAMP-dependent mechanism. AIDS Res Hum Retroviruses. 2006;22(7):619\u201329.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"2","key":"8389_CR54","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1386-6532(02)00123-3","volume":"26","author":"K Kedzierska","year":"2003","unstructured":"Kedzierska K, et al. Defective phagocytosis by human monocyte\/macrophages following HIV-1 infection: underlying mechanisms and modulation by adjunctive cytokine therapy. J Clin Virol. 2003;26(2):247\u201363.","journal-title":"J Clin Virol"},{"issue":"6","key":"8389_CR55","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1086\/506618","volume":"194","author":"V Barreto-de-Souza","year":"2006","unstructured":"Barreto-de-Souza V, et al. Increased Leishmania replication in HIV-1-infected macrophages is mediated by tat protein through cyclooxygenase-2 expression and prostaglandin E2 synthesis. J Infect Dis. 2006;194(6):846\u201354.","journal-title":"J Infect Dis"},{"issue":"12","key":"8389_CR56","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1046\/j.1365-3024.1999.00266.x","volume":"21","author":"SJ Turco","year":"1999","unstructured":"Turco SJ. Adversarial relationship between the leishmania lipophosphoglycan and protein kinase C of host macrophages. Parasite Immunol. 1999;21(12):597\u2013600.","journal-title":"Parasite Immunol"},{"issue":"5","key":"8389_CR57","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1371\/journal.pntd.0000441","volume":"3","author":"R Garg","year":"2009","unstructured":"Garg R, et al. Leishmania infantum amastigotes enhance HIV-1 production in cocultures of human dendritic cells and CD4 T cells by inducing secretion of IL-6 and TNF-alpha. PLoS Negl Trop Dis. 2009;3(5):e441.","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"8389_CR58","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1128\/IAI.67.10.5258-5264.1999","volume":"67","author":"D Wolday","year":"1999","unstructured":"Wolday D, et al. Role of Leishmania donovani and its lipophosphoglycan in CD4+ T-cell activation-induced human immunodeficiency virus replication. Infect Immun. 1999;67(10):5258\u201364.","journal-title":"Infect Immun"},{"issue":"2\u20133","key":"8389_CR59","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0923-2516(91)90062-8","volume":"142","author":"GE Griffin","year":"1991","unstructured":"Griffin GE, et al. Induction of NF-kappa B during monocyte differentiation is associated with activation of HIV-gene expression. Res Virol. 1991;142(2\u20133):233\u20138.","journal-title":"Res Virol"},{"issue":"6","key":"8389_CR60","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.4049\/jimmunol.160.6.2881","volume":"160","author":"R Bernier","year":"1998","unstructured":"Bernier R, et al. The lipophosphoglycan of Leishmania donovani up-regulates HIV-1 transcription in T cells through the nuclear factor-kappaB elements. J Immunol. 1998;160(6):2881\u20138.","journal-title":"J Immunol"},{"issue":"1","key":"8389_CR61","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/003655498750002268","volume":"30","author":"D Wolday","year":"1998","unstructured":"Wolday D, et al. Live and killed human immunodeficiency virus type-1 increases the intracellular growth of Leishmania donovani in monocyte-derived cells. Scand J Infect Dis. 1998;30(1):29\u201334.","journal-title":"Scand J Infect Dis"},{"issue":"Pt 5","key":"8389_CR62","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1099\/vir.0.81647-0","volume":"87","author":"C Zhao","year":"2006","unstructured":"Zhao C, et al. In primary human monocyte-derived macrophages exposed to Human immunodeficiency virus type 1, does the increased intracellular growth of Leishmania infantum rely on its enhanced uptake? J Gen Virol. 2006;87(Pt 5):1295\u2013302.","journal-title":"J Gen Virol"},{"issue":"4","key":"8389_CR63","doi-asserted-by":"crossref","first-page":"436","DOI":"10.4269\/ajtmh.1998.58.436","volume":"58","author":"R Lopez-Velez","year":"1998","unstructured":"Lopez-Velez R, et al. Clinicoepidemiologic characteristics, prognostic factors, and survival analysis of patients coinfected with human immunodeficiency virus and Leishmania in an area of Madrid, Spain. Am J Trop Med Hyg. 1998;58(4):436\u201343.","journal-title":"Am J Trop Med Hyg"},{"issue":"11","key":"8389_CR64","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1128\/JCM.41.11.5080-5084.2003","volume":"41","author":"S Bossolasco","year":"2003","unstructured":"Bossolasco S, et al. Real-time PCR assay for clinical management of human immunodeficiency virus-infected patients with visceral leishmaniasis. J Clin Microbiol. 2003;41(11):5080\u20134.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"8389_CR65","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2133.2008.08908.x","volume":"160","author":"JA Lindoso","year":"2009","unstructured":"Lindoso JA, et al. Unusual manifestations of tegumentary leishmaniasis in AIDS patients from the New World. Br J Dermatol. 2009;160(2):311\u20138.","journal-title":"Br J Dermatol"},{"issue":"9","key":"8389_CR66","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.it.2007.07.004","volume":"28","author":"S Nylen","year":"2007","unstructured":"Nylen S, Sacks D. Interleukin-10 and the pathogenesis of human visceral leishmaniasis. Trends Immunol. 2007;28(9):378\u201384.","journal-title":"Trends Immunol"},{"issue":"7","key":"8389_CR67","doi-asserted-by":"crossref","first-page":"e1002827","DOI":"10.1371\/journal.ppat.1002827","volume":"8","author":"BM Owens","year":"2012","unstructured":"Owens BM, et al. IL-10-producing Th1 cells and disease progression are regulated by distinct CD11c(+) cell populations during visceral leishmaniasis. PLoS Pathog. 2012;8(7):e1002827.","journal-title":"PLoS Pathog"},{"key":"8389_CR68","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.iy.13.040195.001055","volume":"13","author":"SL Reiner","year":"1995","unstructured":"Reiner SL, Locksley RM. The regulation of immunity to Leishmania major. Annu Rev Immunol. 1995;13:151\u201377.","journal-title":"Annu Rev Immunol"},{"issue":"7","key":"8389_CR69","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1128\/IAI.61.7.2952-2959.1993","volume":"61","author":"LC Afonso","year":"1993","unstructured":"Afonso LC, Scott P. Immune responses associated with susceptibility of C57BL\/10 mice to Leishmania amazonensis. Infect Immun. 1993;61(7):2952\u20139.","journal-title":"Infect Immun"},{"key":"8389_CR70","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-065X.1989.tb00557.x","volume":"112","author":"P Scott","year":"1989","unstructured":"Scott P, et al. Role of cytokines and CD4+ T-cell subsets in the regulation of parasite immunity and disease. Immunol Rev. 1989;112:161\u201382.","journal-title":"Immunol Rev"},{"issue":"3","key":"8389_CR71","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0014-4894(89)90120-3","volume":"68","author":"P Scott","year":"1989","unstructured":"Scott P. The role of TH1 and TH2 cells in experimental cutaneous leishmaniasis. Exp Parasitol. 1989;68(3):369\u201372.","journal-title":"Exp Parasitol"},{"issue":"10","key":"8389_CR72","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.4049\/jimmunol.154.10.5320","volume":"154","author":"T Scharton-Kersten","year":"1995","unstructured":"Scharton-Kersten T, et al. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J Immunol. 1995;154(10):5320\u201330.","journal-title":"J Immunol"},{"issue":"9","key":"8389_CR73","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.4049\/jimmunol.164.9.4819","volume":"164","author":"H Himmelrich","year":"2000","unstructured":"Himmelrich H, et al. In BALB\/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease. J Immunol. 2000;164(9):4819\u201325.","journal-title":"J Immunol"},{"issue":"2","key":"8389_CR74","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1574-695X.2007.00311.x","volume":"51","author":"P Tripathi","year":"2007","unstructured":"Tripathi P, Singh V, Naik S. Immune response to leishmania: paradox rather than paradigm. FEMS Immunol Med Microbiol. 2007;51(2):229\u201342.","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"4","key":"8389_CR75","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1365-3083.1994.tb03389.x","volume":"39","author":"D Wolday","year":"1994","unstructured":"Wolday D, et al. HIV-1 inhibits Leishmania-induced cell proliferation but not production of interleukin-6 and tumour necrosis factor alpha. Scand J Immunol. 1994;39(4):380\u20136.","journal-title":"Scand J Immunol"},{"issue":"2","key":"8389_CR76","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1473-3099(03)00517-6","volume":"3","author":"EE Zijlstra","year":"2003","unstructured":"Zijlstra EE, et al. Post-kala-azar dermal leishmaniasis. Lancet Infect Dis. 2003;3(2):87\u201398.","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"8389_CR77","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/00002030-200005260-00003","volume":"14","author":"D Wolday","year":"2000","unstructured":"Wolday D, et al. HIV-1 alters T helper cytokines, interleukin-12 and interleukin-18 responses to the protozoan parasite Leishmania donovani. AIDS. 2000;14(8):921\u20139.","journal-title":"AIDS"},{"issue":"1","key":"8389_CR78","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4269\/ajtmh.1999.60.142","volume":"60","author":"L Nigro","year":"1999","unstructured":"Nigro L, et al. In vitro production of type 1 and type 2 cytokines by peripheral blood mononuclear cells from subjects coinfected with human immunodeficiency virus and Leishmania infantum. Am J Trop Med Hyg. 1999;60(1):142\u20135.","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"8389_CR79","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1046\/j.1365-2249.2002.01749.x","volume":"127","author":"S Milano","year":"2002","unstructured":"Milano S, et al. IL-15 in human visceral leishmaniasis caused by Leishmania infantum. Clin Exp Immunol. 2002;127(2):360\u20135.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"8389_CR80","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.actatropica.2006.08.002","volume":"99","author":"G d\u2019Ettorre","year":"2006","unstructured":"d\u2019Ettorre G, et al. Central role of interleukin-15 in human immunodeficiency virus (HIV)-infected patients with visceral leishmaniasis. Acta Trop. 2006;99(1):83\u20137.","journal-title":"Acta Trop"},{"issue":"Suppl 1","key":"8389_CR81","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1179\/000349803225002561","volume":"97","author":"M Olivier","year":"2003","unstructured":"Olivier M, et al. The pathogenesis of Leishmania\/HIV co-infection: cellular and immunological mechanisms. Ann Trop Med Parasitol. 2003;97(Suppl 1):79\u201398.","journal-title":"Ann Trop Med Parasitol"},{"issue":"3","key":"8389_CR82","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1365-2249.1998.00733.x","volume":"114","author":"FJ Medrano","year":"1998","unstructured":"Medrano FJ, et al. Dynamics of serum cytokines in patients with visceral leishmaniasis and HIV-1 co-infection. Clin Exp Immunol. 1998;114(3):403\u20137.","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"8389_CR83","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s100960000364","volume":"19","author":"JL Villanueva","year":"2000","unstructured":"Villanueva JL, et al. Prospective evaluation and follow-up of European patients with visceral leishmaniasis and HIV-1 coinfection in the era of highly active antiretroviral therapy. Eur J Clin Microbiol Infect Dis. 2000;19(10):798\u2013801.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Suppl 1","key":"8389_CR84","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1179\/000349803225002615","volume":"97","author":"R Lopez-Velez","year":"2003","unstructured":"Lopez-Velez R. The impact of highly active antiretroviral therapy (HAART) on visceral leishmaniasis in Spanish patients who are co-infected with HIV. Ann Trop Med Parasitol. 2003;97(Suppl 1):143\u20137.","journal-title":"Ann Trop Med Parasitol"},{"issue":"9","key":"8389_CR85","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/00002030-200106150-00017","volume":"15","author":"E Rosenthal","year":"2001","unstructured":"Rosenthal E, et al. Declining incidence of visceral leishmaniasis in HIV-infected individuals in the era of highly active antiretroviral therapy. AIDS. 2001;15(9):1184\u20135.","journal-title":"AIDS"},{"issue":"3","key":"8389_CR86","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00126334-200207010-00015","volume":"30","author":"C Tortajada","year":"2002","unstructured":"Tortajada C, et al. Highly active antiretroviral therapy (HAART) modifies the incidence and outcome of visceral leishmaniasis in HIV-infected patients. J Acquir Immune Defic Syndr. 2002;30(3):364\u20136.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"18","key":"8389_CR87","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1097\/00002030-200012220-00021","volume":"14","author":"M Tumbarello","year":"2000","unstructured":"Tumbarello M, et al. Highly active antiretroviral therapy decreases the incidence of visceral leishmaniasis in HIV-infected individuals. AIDS. 2000;14(18):2948\u20139.","journal-title":"AIDS"},{"issue":"11","key":"8389_CR88","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1086\/587899","volume":"46","author":"R Horst ter","year":"2008","unstructured":"ter Horst R, et al. Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome. Clin Infect Dis. 2008;46(11):1702\u20139.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"8389_CR89","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0924-8579(00)00265-X","volume":"16","author":"K Gaetano Donati de","year":"2000","unstructured":"de Gaetano Donati K, et al. Effect of highly active antiretroviral therapy on the incidence of bacterial pneumonia in HIV-infected subjects. Int J Antimicrob Agents. 2000;16(3):357\u201360.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"8389_CR90","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1179\/joc.2003.15.1.60","volume":"15","author":"K Gaetano Donati de","year":"2003","unstructured":"de Gaetano Donati K, et al. Impact of highly active antiretroviral therapy (HAART) on the incidence of bacterial infections in HIV-infected subjects. J Chemother. 2003;15(1):60\u20135.","journal-title":"J Chemother"},{"issue":"10","key":"8389_CR91","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/00002030-199810000-00006","volume":"12","author":"H Albrecht","year":"1998","unstructured":"Albrecht H, et al. Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy. AIDS. 1998;12(10):1149\u201354.","journal-title":"AIDS"},{"issue":"4","key":"8389_CR92","first-page":"268","volume":"125","author":"I Durand","year":"1998","unstructured":"Durand I, et al. Disseminated cutaneous leishmaniasis revealing human immunodeficiency virus infection. Ann Dermatol Venereol. 1998;125(4):268\u201370.","journal-title":"Ann Dermatol Venereol"},{"issue":"1","key":"8389_CR93","doi-asserted-by":"crossref","first-page":"e30307","DOI":"10.1371\/journal.pone.0030307","volume":"7","author":"CM Rueda","year":"2012","unstructured":"Rueda CM, et al. HIV-induced T-cell activation\/exhaustion in rectal mucosa is controlled only partially by antiretroviral treatment. PLoS ONE. 2012;7(1):e30307.","journal-title":"PLoS ONE"},{"issue":"1","key":"8389_CR94","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1128\/IAI.61.1.220-226.1993","volume":"61","author":"T Aebischer","year":"1993","unstructured":"Aebischer T, Moody SF, Handman E. Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: a possible hazard for the host. Infect Immun. 1993;61(1):220\u20136.","journal-title":"Infect Immun"},{"issue":"1","key":"8389_CR95","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0169-4758(94)90353-0","volume":"10","author":"T Aebischer","year":"1994","unstructured":"Aebischer T. Recurrent cutaneous leishmaniasis: a role for persistent parasites? Parasitol Today. 1994;10(1):25\u20138.","journal-title":"Parasitol Today"},{"issue":"11","key":"8389_CR96","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.pt.2004.08.009","volume":"20","author":"CR Engwerda","year":"2004","unstructured":"Engwerda CR, Ato M, Kaye PM. Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis. Trends Parasitol. 2004;20(11):524\u201330.","journal-title":"Trends Parasitol"},{"issue":"2","key":"8389_CR97","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0035-9203(95)90497-2","volume":"89","author":"N Berhe","year":"1995","unstructured":"Berhe N, et al. Ethiopian visceral leishmaniasis patients co-infected with human immunodeficiency virus. Trans R Soc Trop Med Hyg. 1995;89(2):205\u20137.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"14","key":"8389_CR98","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1097\/00002030-199910010-00015","volume":"13","author":"N Berhe","year":"1999","unstructured":"Berhe N, et al. HIV viral load and response to antileishmanial chemotherapy in co-infected patients. AIDS. 1999;13(14):1921\u20135.","journal-title":"AIDS"},{"issue":"1\u20132","key":"8389_CR99","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s004300100082","volume":"190","author":"D Wolday","year":"2001","unstructured":"Wolday D, et al. Emerging Leishmania\/HIV co-infection in Africa. Med Microbiol Immunol. 2001;190(1\u20132):65\u20137.","journal-title":"Med Microbiol Immunol"},{"issue":"8712","key":"8389_CR100","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/0140-6736(90)91945-7","volume":"336","author":"NG Saravia","year":"1990","unstructured":"Saravia NG, et al. Recurrent lesions in human Leishmania braziliensis infection\u2013reactivation or reinfection? Lancet. 1990;336(8712):398\u2013402.","journal-title":"Lancet"},{"issue":"4","key":"8389_CR101","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1084\/jem.183.4.1501","volume":"183","author":"S Stenger","year":"1996","unstructured":"Stenger S, et al. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J Exp Med. 1996;183(4):1501\u201314.","journal-title":"J Exp Med"},{"issue":"2","key":"8389_CR102","doi-asserted-by":"crossref","first-page":"896","DOI":"10.4049\/jimmunol.165.2.896","volume":"165","author":"AY Park","year":"2000","unstructured":"Park AY, Hondowicz BD, Scott P. IL-12 is required to maintain a Th1 response during Leishmania major infection. J Immunol. 2000;165(2):896\u2013902.","journal-title":"J Immunol"},{"issue":"6","key":"8389_CR103","doi-asserted-by":"crossref","first-page":"e1153","DOI":"10.1371\/journal.pntd.0001153","volume":"5","author":"GF Cota","year":"2011","unstructured":"Cota GF, de Sousa MR, Rabello A. Predictors of visceral leishmaniasis relapse in HIV-infected patients: a systematic review. PLoS Neg Trop Dis. 2011;5(6):e1153.","journal-title":"PLoS Neg Trop Dis"},{"issue":"1","key":"8389_CR104","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1128\/IAI.61.1.220-226.1993","volume":"61","author":"T Aebischer","year":"1993","unstructured":"Aebischer T, Moody SF, Handman E. Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: a possible hazard for the host. Infect Immun. 1993;61(1):220\u20136.","journal-title":"Infect Immun"},{"issue":"6915","key":"8389_CR105","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nature01152","volume":"420","author":"Y Belkaid","year":"2002","unstructured":"Belkaid Y, et al. CD4+ CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature. 2002;420(6915):502\u20137.","journal-title":"Nature"},{"issue":"12","key":"8389_CR106","doi-asserted-by":"crossref","first-page":"6967","DOI":"10.4049\/jimmunol.167.12.6967","volume":"167","author":"JE Uzonna","year":"2001","unstructured":"Uzonna JE, et al. Immune elimination of Leishmania major in mice: implications for immune memory, vaccination, and reactivation disease. J Immunol. 2001;167(12):6967\u201374.","journal-title":"J Immunol"},{"issue":"22","key":"8389_CR107","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1182\/blood-2011-07-365874","volume":"118","author":"NR Klatt","year":"2011","unstructured":"Klatt NR, et al. SIV infection of rhesus macaques results in dysfunctional T- and B-cell responses to neo and recall Leishmania major vaccination. Blood. 2011;118(22):5803\u201312.","journal-title":"Blood"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-013-8389-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12026-013-8389-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-013-8389-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T09:30:27Z","timestamp":1688117427000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12026-013-8389-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,16]]},"references-count":107,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["8389"],"URL":"https:\/\/doi.org\/10.1007\/s12026-013-8389-8","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,16]]}}}